Literature DB >> 15710144

A cross-site vascular radiology on-call service: the Manchester experience.

R J Ashleigh1, J S Butterfield, J Asquith, N Chalmers, G Murphy.   

Abstract

AIM: A cross-site vascular radiology on-call service was established 5 years ago to cover two vascular centres in Manchester. We aimed to review the service.
MATERIALS AND METHODS: A prospective audit of out-of hours referrals and procedures over a three month period (March-May 2003) was undertaken.
RESULTS: There were 52 incidents in 49 patients (mean 4 calls per week). Nine involved telephone advice only, the remainder (82%) required a procedure. Angiography was performed on 88% of patients and therapeutic radiological intervention on 50%. 71% of calls occurred at a weekend. 50% of the calls were from vascular surgery and 50% from other sources. The consultant vascular radiologist was present for 93% of procedures.
CONCLUSIONS: The workload suggests that a vascular radiology on call service is justified in Manchester. There have been no major problems with its implementation and operation. This is a consultant led service, with very few cases being devolved to a specialist registrar (SpR).

Entities:  

Mesh:

Year:  2005        PMID: 15710144     DOI: 10.1016/j.crad.2004.10.008

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  2 in total

1.  The RAPTOR: Resuscitation with angiography, percutaneous techniques and operative repair. Transforming the discipline of trauma surgery.

Authors:  Chad G Ball; Andrew W Kirkpatrick; Scott K D'Amours
Journal:  Can J Surg       Date:  2011-10       Impact factor: 2.089

2.  Availability of on-site acute vascular interventional radiology techniques performed by trained acute care specialists: A single-emergency center experience.

Authors:  Junya Tsurukiri; Shoichi Ohta; Shiro Mishima; Hiroshi Homma; Eitaro Okumura; Itsuro Akamine; Masahito Ueno; Jun Oda; Tetsuo Yukioka
Journal:  J Trauma Acute Care Surg       Date:  2017-01       Impact factor: 3.313

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.